New Drugs for Generalized Pustular Psoriasis. Spevigo (spesolimab-sbzo) is an interleukin-36 receptor antagonist approved in September 2024 specifically for the treatment of generalized pustular psoriasis. For more information on other psoriasis drugs, including topical treatments, see Medications for Psoriasis
Drug-induced psoriasis, Psoriasis due to drug eruption, Psoriasis due to adverse drug reaction, Medication-related psoriasis, Drug-aggravated psoriasis.
psoriasis treatment with a focus on the transformative impact of biologic drugs Biologic Medications for the Treatment of Psoriasis
Systemic drugs for psoriasis are typically prescribed when topical treatment fails to adequately treat psoriasis.
Challenges in Diagnosing and Managing Drug-Induced Psoriasis . Diagnosing drug-induced psoriasis can be tricky, especially if you re taking multiple medications. The onset of psoriasis symptoms may occur months or even years after starting a drug, so a full medical history is a key factor in diagnosing drug-induced or drug-related psoriasis.
New Drugs for Generalized Pustular Psoriasis. Spevigo (spesolimab-sbzo) is an interleukin-36 receptor antagonist approved in September 2024 specifically for the treatment of generalized pustular psoriasis. For more information on other psoriasis drugs, including topical treatments, see Medications for Psoriasis
Psoriasis due to adverse drug reaction, Medication-related psoriasis, Drug-aggravated psoriasis Angiotensin-converting enzyme (ACE) inhibitors; Tumour
Upon discontinuation of the implicated drug, the psoriasis exacerbation can decrease (ie, drug-induced psoriasis). Alternatively, the induced psoriatic skin lesions can persist (ie, drug-aggravated psoriasis). Second, a drug can cause onset of new psoriasis lesions at clinically uninvolved skin in a patient with a personal history of psoriasis.
This study confirmed the associations between antihypertensive drugs and psoriasis; ACE inhibitors, BBs, CCBs and thiazide diuretics increased the risk of psoriasis. Therefore, antihypertensive drug users should be carefully monitored for psoriasis.
Comments